UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.017

Sortiert nach

Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon‐like peptide‐1 receptor agonists: A systematic analysis of published clinical trials

Diabetes, obesity & metabolism, 2017-03, Vol.19 (3), p.336-347

2017

Volltextzugriff (PDF)

The efficacy and safety of apremilast, etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from a phase IIIb, randomized, placebo‐controlled trial (LIBERATE)

Journal of the European Academy of Dermatology and Venereology, 2017-03, Vol.31 (3), p.507-517

2017

Volltextzugriff (PDF)

A Phase IIb Study of ABT‐494, a Selective JAK‐1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti–Tumor Necrosis Factor Therapy

Arthritis & rheumatology (Hoboken, N.J.), 2016-12, Vol.68 (12), p.2867-2877

2016

Volltextzugriff (PDF)

Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline

Pediatric blood & cancer, 2022-12, Vol.69 (12), p.e30001-n/a

2022

Volltextzugriff (PDF)

Guideline for the prevention of acute chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A focused update

Pediatric blood & cancer, 2017-10, Vol.64 (10), p.n/a

2017

Volltextzugriff (PDF)

Metagenomics and chemotherapy‐induced nausea: A roadmap for future research

Cancer, 2022-02, Vol.128 (3), p.461-470

2022

Volltextzugriff (PDF)

Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer

Cancer, 2020-01, Vol.126 (2), p.354-362

2020

Volltextzugriff (PDF)

Patients’ perception of chemotherapy side effects: Expectations, doctor–patient communication and impact on quality of life – An Italian survey

European journal of cancer care, 2017-03, Vol.26 (2), p.e12618-n/a

2017

Volltextzugriff (PDF)

A Coala‐T‐Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment

Cancer, 2022-01, Vol.128 (1), p.160-168

2022

Volltextzugriff (PDF)

Safety, Pharmacokinetics, and Pharmacodynamics of the Oral TLR8 Agonist Selgantolimod in Chronic Hepatitis B

Hepatology (Baltimore, Md.), 2021-10, Vol.74 (4), p.1737-1749

2021

Volltextzugriff (PDF)

Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline

Pediatric blood & cancer, 2019-05, Vol.66 (5), p.e27646-n/a

2019

Volltextzugriff (PDF)

Treatment of breakthrough and prevention of refractory chemotherapy‐induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update

Pediatric blood & cancer, 2023-08, Vol.70 (8), p.e30395-n/a

2023

Volltextzugriff (PDF)

The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract

Alimentary pharmacology & therapeutics, 2010-03, Vol.31 (5), p.548-552

2010

Volltextzugriff (PDF)

British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016

British journal of dermatology (1951), 2016-07, Vol.175 (1), p.23-44

2016

Volltextzugriff (PDF)

Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes

Diabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.378-388

2018

Volltextzugriff (PDF)

An assessment of the effects of neurokinin 1 receptor antagonism against nausea and vomiting: Relative efficacy, sites of action and lessons for future drug development

British journal of clinical pharmacology, 2023-12, Vol.89 (12), p.3468-3490

2023

Volltextzugriff (PDF)

Pediatric oncology provider perspectives and patient/family perceptions of chemotherapy‐induced nausea and vomiting management: Experiences at an academic medical center

Pediatric blood & cancer, 2024-04, Vol.71 (4), p.e30883-n/a

2024

Volltextzugriff (PDF)

Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma

British journal of haematology, 2017-08, Vol.178 (4), p.571-582

2017

Volltextzugriff (PDF)

Cannabidiolic acid prevents vomiting in Suncus murinus and nausea‐induced behaviour in rats by enhancing 5‐HT1A receptor activation

British journal of pharmacology, 2013-03, Vol.168 (6), p.1456-1470

2013

Volltextzugriff (PDF)

Minimal important difference in postoperative morphine consumption after hip and knee arthroplasty using nausea, vomiting, sedation and dizziness as anchors

Acta anaesthesiologica Scandinavica, 2024-05, Vol.68 (5), p.610-618

2024

Volltextzugriff (PDF)

Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases

Journal of forensic sciences, 2019-01, Vol.64 (1), p.270-274

2019

Volltextzugriff (PDF)

Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials

Diabetes, obesity & metabolism, 2018-09, Vol.20 (9), p.2210-2219

2018

Volltextzugriff (PDF)

Cannabinoid hyperemesis syndrome in pregnancy: Challenges and opportunities

Australian & New Zealand journal of obstetrics & gynaecology, 2023-12, Vol.63 (6), p.746-752

2023

Volltextzugriff (PDF)

Prevention and treatment of anticipatory chemotherapy‐induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update

Pediatric blood & cancer, 2021-05, Vol.68 (5), p.e28947-n/a

2021

Volltextzugriff (PDF)

Willingness to bear adversity and beliefs about the curability of advanced cancer in older adults

Cancer, 2019-07, Vol.125 (14), p.2506-2513

2019

Volltextzugriff (PDF)

1 – 25 von 1.017

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(968)
Mit Volltextzugriff
(850)

Publikationsform

Artikel
(1.017)

Sprache

Englisch
(1.017)
Japanisch
(121)

Erscheinungsjahr

n.n

Thema

Humans
(994)
Science & Technology
(896)
Life Sciences & Biomedicine
(894)
Nausea - Chemically Induced
(821)
Female
(717)
Male
(644)
Adult
(561)
Middle Aged
(528)
Vomiting - Chemically Induced
(448)
Biological And Medical Sciences
(408)
Medical Sciences
(406)
Aged
(370)
Pharmacology. Drug Treatments
(275)
Oncology
(222)
Adolescent
(214)
Nausea
(207)
Double-Blind Method
(193)
Treatment Outcome
(181)
Pharmacology & Pharmacy
(166)
Antineoplastic Agents - Adverse Effects
(165)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon‐like peptide‐1 receptor agonists: A systematic analysis of published clinical trials

The efficacy and safety of apremilast, etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from a phase IIIb, randomized, placebo‐controlled trial (LIBERATE)

A Phase IIb Study of ABT‐494, a Selective JAK‐1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti–Tumor Necrosis Factor Therapy

Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline

Guideline for the prevention of acute chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A focused update

Metagenomics and chemotherapy‐induced nausea: A roadmap for future research

Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer

Patients’ perception of chemotherapy side effects: Expectations, doctor–patient communication and impact on quality of life – An Italian survey

A Coala‐T‐Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment

Safety, Pharmacokinetics, and Pharmacodynamics of the Oral TLR8 Agonist Selgantolimod in Chronic Hepatitis B

Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline

Treatment of breakthrough and prevention of refractory chemotherapy‐induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update

The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract

British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016

Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes

An assessment of the effects of neurokinin 1 receptor antagonism against nausea and vomiting: Relative efficacy, sites of action and lessons for future drug development

Pediatric oncology provider perspectives and patient/family perceptions of chemotherapy‐induced nausea and vomiting management: Experiences at an academic medical center

Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma

Cannabidiolic acid prevents vomiting in Suncus murinus and nausea‐induced behaviour in rats by enhancing 5‐HT1A receptor activation

Minimal important difference in postoperative morphine consumption after hip and knee arthroplasty using nausea, vomiting, sedation and dizziness as anchors

Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases

Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials

Cannabinoid hyperemesis syndrome in pregnancy: Challenges and opportunities

Prevention and treatment of anticipatory chemotherapy‐induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update

Willingness to bear adversity and beliefs about the curability of advanced cancer in older adults

Aktive Filter

Suchergebnisse filtern